Relay Therapeutics
RLAY
RLAY
165 hedge funds and large institutions have $1.9B invested in Relay Therapeutics in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 38 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 161 → 165 (+4)
31% less capital invested
Capital invested by funds: $2.76B → $1.9B (-$864M)
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
165
Holding in Top 10
2
Calls
$1.7M
Puts
$3K
Top Buyers
| 1 | +$38.8M | |
| 2 | +$30.3M | |
| 3 | +$30.2M | |
| 4 |
BlackRock
New York
|
+$18.5M |
| 5 |
FC
Finepoint Capital
Boston,
Massachusetts
|
+$10.7M |
Top Sellers
| 1 | -$33.2M | |
| 2 | -$24.7M | |
| 3 | -$20.2M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$16.1M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$8.95M |